Surgeon: Dr. Isabelle SMOLIK / Dr. Pierre Escalas
Sourdille Atlantique Ophthalmological Institute Nantes / Saint Herblain
Presentation during the "Oculoplastic Academy" congress in Nantes 2014
Infectious and cicatricial complication following a well-conducted procedure but in a patient treated with anti-TNF alpha (Humira®) that was stopped 6 weeks prior
These immunosuppressant-type treatments are increasingly used to treat dysimmune diseases and must be discontinued before surgery with a delay that depends on the half-life of the product.
The videos have been created and produced with great care to be as relevant as possible. Many topics are subject to controversy, and the options presented are rational personal choices resulting from experience representing several thousand interventions. Other approaches are possible and may have been suggested to you; do not hesitate to ask about the reasons for the choices that were made.
This site is only a guide and does not replace explanations during consultation, which are essential to understanding the analysis of your facial characteristics, which are unique.
Similarly, the examples presented help to understand the principles of eye surgery, but they are not necessarily transferable to your particular situation. Therefore, it is not possible to guarantee the results that you may have seen in the various presentations.
By using this site, you accept these limitations. If you do not agree, please do not use it.